Published on 31 Mar 2022 on Zacks via Yahoo Finance
Spero Therapeutics, Inc. (SPRO) came out with a quarterly loss of $0.90 per share versus the Zacks Consensus Estimate of a loss of $0.80. This compares to loss of $0.68 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -12.50%. A quarter ago, it was expected that this company would post a loss of $0.70 per share when it actually produced a loss of $0.70, delivering no surprise.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.